Neostigmine Methyl Sulfate – Cholinesterase Inhibitor API
Basic Information
▸ Product Name: Neostigmine Methyl Sulfate
▸ CAS Number: 80449-31-6
▸ Standard: In-House / IP / EP / BP
▸ Category: Cholinesterase inhibitor
▸ Intended Use: Human and veterinary pharmaceutical formulations
Mechanism of Action
Neostigmine Methyl Sulfate works by inhibiting the enzyme acetylcholinesterase, which breaks down acetylcholine in the synaptic cleft. By slowing this breakdown, the concentration and duration of acetylcholine activity are increased at neuromuscular junctions and parasympathetic nerve endings.
This mechanism enhances skeletal muscle contraction, improves neuromuscular transmission, and stimulates smooth muscle activity, particularly in the gastrointestinal tract.
Applications in Medicine
Treatment of Myasthenia Gravis
Neostigmine Methyl Sulfate is widely used in the treatment of myasthenia gravis, a chronic autoimmune neuromuscular disorder characterized by muscle weakness and fatigue. By increasing acetylcholine availability at neuromuscular junctions, it improves muscle strength and enhances voluntary muscle control.
Reversal of Neuromuscular Blockade
It is commonly administered after surgical procedures to reverse the effects of non-depolarizing neuromuscular blocking agents such as gallamine and tubocurarine. By elevating acetylcholine levels, it counteracts residual muscle relaxation and supports safe recovery following anesthesia.
Potential Use in Postoperative Ileus
Neostigmine Methyl Sulfate has also shown clinical utility in managing postoperative ileus, a temporary reduction in bowel motility following surgery. Intravenous administration may stimulate intestinal movement and relieve symptoms in selected cases, although further research continues to refine its therapeutic role.
Key Advantages
▸ Proven and well-understood pharmacological mechanism
▸ Effective enhancement of neuromuscular transmission
▸ Widely applied in surgical and neuromuscular care
▸ Suitable for both human and veterinary pharmaceutical formulations
▸ Manufactured in accordance with major pharmacopoeial standards
Quality and Compliance
Neostigmine Methyl Sulfate API is produced in accordance with recognized international standards including IP, EP, and BP. Strict quality control procedures ensure batch consistency, high purity, and full suitability for pharmaceutical manufacturing across multiple therapeutic applications.
Applicable Fields
▸ Human pharmaceutical formulations
▸ Veterinary pharmaceutical formulations
▸ Neuromuscular therapy
▸ Anesthesia recovery management
▸ Gastrointestinal motility treatment
Factory Audit & Customer Support
Customers are welcome to visit our manufacturing facilities for quality audits and inspections. Factory visits can be arranged by appointment, and our technical and quality teams provide comprehensive documentation, regulatory support, and responsive service.
Summary
Neostigmine Methyl Sulfate is a trusted cholinesterase inhibitor with essential applications in neuromuscular disorders, anesthesia recovery, and gastrointestinal motility management. Its ability to enhance acetylcholine activity makes it an indispensable API for both human and veterinary pharmaceutical manufacturing worldwide.
Hot Tags: neostigmine methyl sulfate cholinesterase inhibitor, China neostigmine methyl sulfate cholinesterase inhibitor manufacturers, suppliers, factory, small molecular entities for veterinary drug screening, Pradofloxacin CAS 195532 12 8, Small Molecular Compounds for Veterinary, Pimobendan CAS 74150 27 9, Dexmedetomidine Hydrochloride, Neostigmine Methyl Sulfate CAS 51 60 5










